Close

JPMorgan Downgrades Aspen Aerogels (ASPN) to Neutral

Go back to JPMorgan Downgrades Aspen Aerogels (ASPN) to Neutral

Aspen Aerogels (ASPN) Numbers Cut at Needham & Company Posts Q3

November 4, 2016 6:59 AM EDT

Needham & Company analyst Sean K.F. Hannan lowered estimates and his price target on Aspen Aerogels (NYSE: ASPN) to $8.00 (from $9.50) but maintained a Buy rating following results.

Hannan commented, "We continue to view ASPN as a uniquely positioned materials technology company with a strong patent... More

Aspen Aerogels (ASPN) Misses Q3 EPS by 4c; Trims Outlook

November 4, 2016 6:18 AM EDT

Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $29.6 million versus the consensus estimate of $29.05 million.

GUIDANCE:

Aspen Aerogels sees FY2016 EPS of ($0.46)-($0.41), versus prior guidance of... More